Beguin Y. Erythropoiesis and erythropoietin in multiple myeloma. Leuk Lymphoma . Beguin Y, Verna M, Loo M, et al. Br J Haematol . Spivak JL, Pham T, Isaacs M, et al.
Erythropoietin is both a mitogen and a survival factor.
Casati S, Passerini P, Campise MR, et al. Benefits and risks of protracted treatment with human recombinant erythropoietin in patients having haemodialysis. Br Med J . Taylor J, Mactire RA, Stewart WK, et al. The effect of erythropoietin on anemia in patients with myeloma receiving haemodialysis.